Related Experiment Videos
[Information on mammography screening--from deception to insight]
1Universität Hamburg, FB13-IGTW-Gesundheit, Martin-Luther-King-Platz 6, 20146 Hamburg. Ingrid_Muehlhauser@uni-hamburg.de
Der Radiologe
|June 18, 2002
Summary
Informed decisions about mammography screening require unbiased, evidence-based information. This includes clear communication of benefits like reduced breast cancer mortality and harms such as overdiagnosis and overtreatment.
Area of Science:
- Medical Screening
- Public Health Communication
- Evidence-Based Medicine
Background:
- Mammography screening is a key tool for breast cancer detection.
- Effective communication of screening outcomes is crucial for informed patient decisions.
- Current communication often lacks balance, potentially leading to biased understanding.
Purpose of the Study:
- To outline principles for unbiased communication of mammography screening information.
- To ensure patients receive comprehensive data on benefits and harms.
- To promote evidence-based decision-making in cancer screening.
Main Methods:
- Review of evidence on mammography screening effectiveness (mortality reduction).
- Analysis of mammography test performance metrics (sensitivity, specificity, predictive values).
- Evaluation of potential harms including false positives, false negatives, overdiagnosis, and overtreatment.
Main Results:
- Effective communication requires presenting both benefits (e.g., reduced breast cancer mortality) and harms (e.g., overdiagnosis, overtreatment).
- Data should be communicated using natural frequencies, not relative differences, to avoid framing effects.
- Equal emphasis must be given to those likely to benefit and those unlikely to benefit or likely to be harmed.
Conclusions:
- Unbiased presentation of mammography screening data is essential for informed decision-making.
- Communicating outcomes as natural frequencies enhances understanding of screening effectiveness and risks.
- A balanced approach, highlighting both benefits and harms, supports patient autonomy in screening choices.